Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
1.910
-0.020 (-1.04%)
At close: Jun 17, 2025, 4:00 PM
1.879
-0.031 (-1.61%)
Pre-market: Jun 18, 2025, 8:00 AM EDT
Cronos Group Revenue
Cronos Group had revenue of $32.26M in the quarter ending March 31, 2025, with 27.58% growth. This brings the company's revenue in the last twelve months to $124.59M, up 33.92% year-over-year. In the year 2024, Cronos Group had annual revenue of $117.62M with 34.82% growth.
Revenue (ttm)
$124.59M
Revenue Growth
+33.92%
P/S Ratio
5.89
Revenue / Employee
$271,436
Employees
459
Market Cap
734.19M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 117.62M | 30.37M | 34.82% |
Dec 31, 2023 | 87.24M | 492.00K | 0.57% |
Dec 31, 2022 | 86.75M | 22.19M | 34.37% |
Dec 31, 2021 | 64.56M | 17.84M | 38.19% |
Dec 31, 2020 | 46.72M | 22.97M | 96.71% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CRON News
- 6 days ago - 3 Marijuana Stocks For Longterm Investors - MarijuanaStocks
- 11 days ago - Marijuana Stocks To Watch With Strong Market Potential - MarijuanaStocks
- 15 days ago - Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer Conference - GlobeNewsWire
- 27 days ago - Cronos Group: Industry Fortress Balance Sheet And FCF Create A Solid Upside Potential - Seeking Alpha
- 27 days ago - Top Marijuana Stocks In A Volatile Market - MarijuanaStocks
- 4 weeks ago - Cronos Reports Improved Financials For Q1-2025 As Demand Outpaces Supply - Seeking Alpha
- 5 weeks ago - Top 3 Marijuana Stocks For Better Investing 2025 - MarijuanaStocks
- 5 weeks ago - Cronos Group Inc. (CRON) Q1 2025 Earnings Call Transcript - Seeking Alpha